Top Markets
Coin of the day
Deltex Medical Group plc Deltex Medical Group plc

Deltex Medical Group plc

DEMG
株式のランク #41840
Deltex Medical Group plc, established in 2000 and headquartered in Chichester,... Deltex Medical Group plc, established in 2000 and headquartered in Chichester, UK, specializes in the development, marketing, and distribution of oesophageal Doppler haemodynamic monitoring systems. These TrueVue-branded solutions are available across the United Kingdom, United States, Spain, Canada, and other international territories. The company's product line includes Esophageal Doppler Probes, which offer real-time insights into central vascular blood flow and fluid status by measuring blood velocities in the descending aorta. Loops graphically illustrates aortic blood flow velocity and pressure throughout each heartbeat, while High Definition Impedance Cardiography provides non-invasive monitoring of cardiac function and fluid balance for conscious patients. Additionally, PressureWave utilizes a pulse pressure waveform analysis algorithm, designed for use during patient instability or when the primary ODM mode is inaccessible. Deltex Medical also supports professional development with its Esophageal Doppler Simulator, allowing clinicians to refine their skills in probe insertion, focusing, and waveform interpretation in a controlled, non-patient environment. These sophisticated monitoring tools are crucial in various medical applications, including intensive care for COVID-19 patients, sepsis management, major surgical procedures (such as abdominal, laparoscopic, and spinal surgeries), cardiac interventions, trauma care, organ transplantation, and post-operative monitoring for acute kidney injury.
株価
$0.00032657
最終同期: 2025-02-20
時価総額
$9.03K
変化(1日)
-25.84%
変化(1年)
0.00%
GB
取引 Deltex Medical Group plc (DEMG)

カテゴリー

Deltex Medical Group plc(DEMG)のP/E比率
2026 時点のP/E比率 TTM 0
Deltex Medical Group plc の最新の財務報告および株価によると、現在の P/E (TTM) は 0 です。2026 年末時点での P/E は 0 でした。
Deltex Medical Group plc の P/E 比率の履歴(2026 〜 2026)
各年末のP/E比率
P/E比率 変化
提供された日付のデータは十分ではありません。
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
33.99 -
US
33.47 -
US
21.39 -
IE
18.84 -
US
49.47 -
US
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。